Mose et al. reported Sfrp1 epithelial–mesenchymal transition phenotype induction in tumor cells without affecting tumor-intrinsic Wnt signaling, suggesting involvement of non-immune stromal cells. This evidence concerns the gene SFRP1 and neoplasm.